Navigation Links
FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
Date:5/2/2011

ith TRADJENTA, physicians will have another option for managing type 2 diabetes, a potentially devastating condition."

TRADJENTA 5 mg once daily was approved based on a clinical trial program which included approximately 4,000 adults with type 2 diabetes. Included in the program were placebo-controlled studies evaluating TRADJENTA as monotherapy and in combination with the commonly prescribed medications for type 2 diabetes –  metformin, sulfonylurea or pioglitazone. TRADJENTA showed statistically significant A1C reductions of up to 0.7 percent when used as monotherapy (compared to placebo). When used in combination with metformin, sulfonylurea, and metformin plus sulfonylurea, the addition of TRADJENTA resulted in significant A1C reductions of 0.6, 0.5, and 0.6 percent respectively (compared to placebo). In the initial combination of TRADJENTA plus pioglitazone, significant reductions in A1C of 0.5 percent were observed compared to placebo.  

Treatment with TRADJENTA also produced significant reductions in fasting plasma glucose (FPG) compared to placebo, when used as monotherapy and in combination with metformin, sulfonylurea or pioglitazone. Treatment with TRADJENTA produced significant reductions in two-hour post-prandial glucose (PPG) levels compared with placebo as monotherapy and when used in combination with metformin. FPG is used to determine glucose levels in a fasting state (usually upon wakening in the morning), and PPG is used to determine glucose levels after meals (usually two hours after eating).

In controlled studies, change from baseline in body weight did not differ significantly between groups when TRADJENTA was administered as monotherapy, in combination with metformin or in combination with metformin plus sulfonylurea. Patients treated with TRADJENTA exhibited a significant mean decrease from baseline body weight compared to a significant weight gain in patients administered sulfonylurea (-1.1 kg vs. +1.4 kg
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... SAN FRANCISCO , August 3, 2015 /PRNewswire/ ... size is expected to reach USD 24.7 ... by Grand View Research Inc. Growing prevalence of ... the physiotherapy equipments market over the forecast period. ... as ultrasound and cryotherapy, advancement in the technologies ...
(Date:8/3/2015)... , Aug. 3, 2015  Dr. ... Orthopaedic & Spine Center today, providing ... manage their chronic pain through psychological counseling and ... is a Fellowship-trained, certified medical psychologist with an ... His vast experience ranges from assessment and treatment ...
(Date:8/3/2015)... Corporation (NASDAQ: CYTR ), a biopharmaceutical research and ... for the three months ended June 30, 2015, and ... milestones for its clinical development programs. "The ... CytRx. Enrollment in our ongoing pivotal global Phase 3 ... continues on track to be completed in the first ...
Breaking Medicine Technology:Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5Orthopaedic & Spine Center Introduces New Pain Psychologist 2CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14
... Oct. 19, 2011  CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical ... Adhesion Kinase (FAK) inhibitors for cancer, announced today that ... present a company overview at the Biotechnology Industry Organization,s ... Francisco, CA on Wednesday, October 26 at 9:00 am. ...
... Oct. 19 2011 Varian Medical Systems (NYSE: ... X-Ray imaging technology, is announcing the publication of its ... company,s policies and achievements in extending care, protecting resources ... has been produced as part of the wider investment ...
Cached Medicine Technology:CureFAKtor Pharmaceuticals to Present at 10th Annual BIO Investor Forum 2Varian Medical Systems Publishes First Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements 2
(Date:8/3/2015)... ... August 03, 2015 , ... ... the largest online retailer of nutritional supplements, has officially opened the polls ... 11 awards in the following categories:, ,     Brand of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Social impact organization’s ... 3, 2015 – Since winning a South by Southwest® (SXSW®) Interactive Innovation Award ... organization whose mission is to develop technology for the sake of humanity – ...
(Date:8/3/2015)... ... August 03, 2015 , ... The art of preparing and cooking food comes ... at a young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now ... Recipes from My Persian Kitchen with the world. , Since Americans tend to be ...
(Date:8/3/2015)... ... August 03, 2015 , ... AxoGen, Inc. (NASDAQ: AXGN), a leader ... present at the Wedbush Healthcare Conference on Wednesday, August 12, 2015 at 9:45am (ET) ... archived replay of the Company’s presentation may be accessed via the investor relations section ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its least visited ... untapped ground water aquifers, whose main outflow is at Ahjumawi Lava Springs, part ...
Breaking Medicine News(10 mins):Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4
... a greater risk , than they might think SCHAUMBURG, ... 1 million cases of skin cancer ... historically those most at risk for developing skin cancer are ... generally older populations, dermatologists advise that those who do not ...
... A new survey from Noblis Health Innovation, a leading ... of the current economic crisis, nearly a third of hospitals are ... in April 2009, the affiliation study is the first in a ... Insights Panel , a collection of more than 150 leading health ...
... 2009A new review finds hospital volume to be a ... studies, when combined, show a quantifiable and statistically significant ... finds that individual studies often fail to show such ... at best an imperfect proxy for healthcare quality. , ...
... implicated in cardiovascular disease risk for 5000 years. ... investigators from Germany at the University of Erlangen, ... Berlin-Buch and Regensburg, collaborating with researchers from Finland ... relationship between salt intake, bodily processes, and blood ...
... Millennium Research Group releases latest editions of its ... the cardiovascular, endoscopy, orthopedics, aesthetics, and imaging and ... Research Group (MRG), the global authority on medical ... 2009 issues of its Industry Quarterly (IQ) ...
... and not drinking enough water are to blame.ANN ARBOR, ... call from her daughter,s daycare saying that 3-year-old Emma ... cause would be a condition often associated with middle ... over in pain and saying that her back hurt ...
Cached Medicine News:Health News:Consumer Alert: Dermatologists Warn Skin Cancer is an Equal-Opportunity Health Threat 2Health News:Consumer Alert: Dermatologists Warn Skin Cancer is an Equal-Opportunity Health Threat 3Health News:Consumer Alert: Dermatologists Warn Skin Cancer is an Equal-Opportunity Health Threat 4Health News:Consumer Alert: Dermatologists Warn Skin Cancer is an Equal-Opportunity Health Threat 5Health News:Noblis Insights Panel Finds Growing Interest in Hospital Affiliation as a Strategic Response to Challenging Market Conditions 2Health News:Noblis Insights Panel Finds Growing Interest in Hospital Affiliation as a Strategic Response to Challenging Market Conditions 3Health News:Hospital volume inconsistent predictor of quality care 2Health News:New light shed on the enigma of salt intake and hypertension 2Health News:Despite the Economic Downturn, Long-Term Growth Potential in the US Dental Biomaterial Market Remains Robust 2Health News:Kidney Stones in Children on The Rise, U-M Expert Says 2Health News:Kidney Stones in Children on The Rise, U-M Expert Says 3
Cardboard Block Filing Cabinet is an economical solution for block storage needs....
Scienceware® Slide Tray Cabinet holds twelve Scienceware® H44581 microscope trays horizontally in a dust free enclosure....
Compact storage cabinets for 35 mm slides....
Seasoned oak cabinet with flat sides and disappearing door...
Medicine Products: